EUVIMEDEUVIMED entdecken
Crossref

Exploring the Anti‐Tubercular Potential of 2‐(1 H ‐Pyrazol‐1‐yl) Pyrimidine: Design, Synthesis, Biological Evaluation and Molecular Docking Studies

Mahesh Kumar Talamadla iD, Adinarayana Nandikolla iD, Singarapalle Shobha, Pranav Pramod Nayar, Muthyala Murali Krishna Kumar, Murugesan Sankaranarayanan, Kondapalli Venkata Gowri Chandra Sekhar iD

Chemistry & Biodiversity · 2025

DOI: 10.1002/cbdv.202500321 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemistry & Biodiversity, 2025. Verfasst von Mahesh Kumar Talamadla und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Birla Institute of Technology and Science, Pilani, Hyderabad Campus, Hyderabad, Telangana, India. Hauptthemen laut MEDLINE: Molecular Docking Simulation, Mycobacterium tuberculosis, Antitubercular Agents, Pyrimidines. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 30 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We designed and synthesised pyrazolyl pyrimidine‐containing derivatives and screened for anti‐mycobacterial activity. Key intermediate 4‐chloro‐2‐(3,5‐dimethyl‐1H‐pyrazol‐1‐yl)‐6‐methyl pyrimidine is prepared via the literature‐reported protocol. From this intermediate, the two sets of final compounds were prepared. Different spectral techniques like HRMS, 1 H, and 13 C NMR are deployed for the structural confirmation of final derivatives. Final compounds were screened against the Mycobacterium tuberculosis H37Rv strain. Using microplate alamar blue assay, the concentration of compound required to inhibit bacterial growth was assessed. Rifampicin was used as a standard, whose minimum inhibitory concentration (MIC) is 3.12 µg/mL. MIC values of the synthesised compounds varied from 6.25 to 25 µg/mL. Three derivatives, F‐2 , F‐5 and F‐9 among the synthesised, are most active with MIC values of 6.25 µg/mL. F‐2 , F‐5 and F‐9 compounds were also screened for their cytotoxicity against normal cells, where F‐9 has shown selectivity over normal human embryonic kidney cell lines (HEK293T). In silico ADME was evaluated using the SWISS ADME tool. Docking studies were carried out for F‐2 , F‐5 and F‐9 at the active site of InhA (PDB ID: 4TZK), the enoyl acyl carrier protein reductase. MD simulations were carried out for F‐9 to assess the stability of the protein–ligand complex.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Molecular Docking SimulationMycobacterium tuberculosisAntitubercular AgentsPyrimidinesDrug DesignPyrazolesHumansMicrobial Sensitivity TestsStructure-Activity RelationshipMolecular StructureHEK293 CellsDose-Response Relationship, DrugCell Survival

Stichwörter der Autor:innen

anti‐tuberculosisdockingpiperidinyl benzamidespiperidinyl methanonespyrazolyl pyrimidines

Substanzen

Antitubercular AgentsPyrimidinesPyrazoles

Autor:innen und Institutionen

  • Department of Chemistry, Birla Institute of Technology and Science, Pilani, Hyderabad Campus, Hyderabad, Telangana, India.
  • College of Pharmaceutical Sciences, Andhra University, Visakhapatnam, Andhra Pradesh, India.
  • Medicinal Chemistry Research Laboratory, Department of Pharmacy, Birla Institute of Technology and Science Pilani, Pilani Campus, Pilani, Rajasthan, India.

ORCID-Profile: Mahesh Kumar Talamadla, Adinarayana Nandikolla, Kondapalli Venkata Gowri Chandra Sekhar

Zitieren

APA

Talamadla, M. K., Nandikolla, A., Shobha, S., Nayar, P. P., Kumar, M. M. K., Sankaranarayanan, M., & Sekhar, K. V. G. C. (2025). Exploring the Anti‐Tubercular Potential of 2‐(1 H ‐Pyrazol‐1‐yl) Pyrimidine: Design, Synthesis, Biological Evaluation and Molecular Docking Studies. Chemistry & Biodiversity. https://doi.org/10.1002/cbdv.202500321

Vancouver

Talamadla MK, Nandikolla A, Shobha S, Nayar PP, Kumar MMK, Sankaranarayanan M, et al. Exploring the Anti‐Tubercular Potential of 2‐(1 H ‐Pyrazol‐1‐yl) Pyrimidine: Design, Synthesis, Biological Evaluation and Molecular Docking Studies. Chemistry & Biodiversity. 2025. doi:10.1002/cbdv.202500321

BibTeX
@article{Talamadla2025,
  author = {Talamadla, Mahesh Kumar and Nandikolla, Adinarayana and Shobha, Singarapalle and Nayar, Pranav Pramod and Kumar, Muthyala Murali Krishna and Sankaranarayanan, Murugesan and Sekhar, Kondapalli Venkata Gowri Chandra},
  title = {Exploring the Anti‐Tubercular Potential of 2‐(1 H ‐Pyrazol‐1‐yl) Pyrimidine: Design, Synthesis, Biological Evaluation and Molecular Docking Studies},
  journal = {Chemistry & Biodiversity},
  year = {2025},
  doi = {10.1002/cbdv.202500321}
}
Kostenlos starten →